ORN Spring 2022 #2 - Case Studies and QandA: The impact of illicit fentanyl use on opioid use disorder treatment-Event Recording

Video Transcription

Video Summary

In this webinar, Dr. Andrew Hoon discusses the impact of illicit fentanyl use on opioid use disorder treatment. He focuses on buprenorphine induction and treatment strategies for individuals who use fentanyl. The webinar explores different approaches to buprenorphine inductions, including low-dose initiations, high-dose buprenorphine inductions, and an opioid drought method. The importance of extended-release naltrexone, methadone, and Tramadol ER as alternative treatment options is also discussed. Dr. Hoon emphasizes the need for further research to understand the unique challenges posed by fentanyl use and to optimize treatment outcomes for individuals with opioid use disorder. The webinar concludes with a Q&A session where participants address questions about buprenorphine induction protocols, maintenance doses for fentanyl users, transitions from methadone to buprenorphine, and more. The webinar is part of a series on hot topics in the treatment of opioid use disorder and stimulant use disorders, and is funded by SAMHSA.

Keywords

webinar

illicit fentanyl use

opioid use disorder treatment

buprenorphine induction

treatment strategies

fentanyl users

alternative treatment options

research

challenges

SAMHSA